Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sonoma Pharmaceuticals Logo
Sonoma Pharmaceuticals Growth Score
90
CB Rank
26913
Heat Score
73
Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.
Founded
obfuscation
PublicPost-IPO Equity Boulder, Colorado, United States1-10 sonomapharma.com/
Health Care
Overview

Sonoma Pharmaceuticals
Total Funding
obfuscation
Growth Score
90
Heat Score
73

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score90
-4 pts
in past quarter
Heat Score 73
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Sonoma Pharmaceuticals

CB Rank
26913
Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.
Founded
obfuscation
PublicPost-IPO Equity Boulder, Colorado, United States1-10 sonomapharma.com/
Health Care

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name SONOMA PHARMACEUTICALS, INC.
Also Known As Oculus Innovative Sciences
Operating Status Active
Stock Symbol  NASDAQ:SNOA
Company Type For Profit
Founders  Hojabr Alimi, Linda Alimi
About the Company

Sonoma Pharmaceuticals is a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries. The company’s products, over 100 SKUs commercialized worldwide, are used to treat patients in advanced wound management, dermatology, women’s health and animal health; addressing the unmet medical

needs of these markets—while raising the standard of patient care and lowering overall healthcare costs.

Phone Number 800-759-9305
Contact Email customerservice@sonomapharma.com
Diversity Spotlight 
Women Led
Predictions & Insights

Growth Insight

See this Growth Insight
Sonoma Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Regenacyn
A topical antimicrobial solution used for wound care to reduce microbial contamination and support tissue healing.
HOCl-based burn relief hydrogel
An advanced hypochlorous acid-based hydrogel for consumer burn relief and minor skin irritations.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sonoma Pharmaceuticals Logo
Post-IPO Equity - Sonoma Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 5 Board Members and Advisors 1 Contacts 22

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,948
-65.15%
 in past month

IT Spend

$323.6KThis year, Sonoma Pharmaceuticals is projected to spend $323.6K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Oracle (ORCL) Logo
Oracle (ORCL)
82
Reuters Logo
Reuters
81
Salesforce (CRM) Logo
Salesforce (CRM)
81

Actively Used Products

11Sonoma Pharmaceuticals uses 11 technology products and services including HTML5, GlobalSign, and  jQuery, according to G2 Stack.

Active Website Tech Count

40Sonoma Pharmaceuticals is actively using 40 technologies for its website, according to BuiltWith. These include DNSSEC, Cloudflare CDN, and  Cloudflare.
Sub-Organizations
Frequently Asked Questions

Where is Sonoma Pharmaceuticals's headquarters? Sonoma Pharmaceuticals is located in Boulder, Colorado, United States.Who invested in Sonoma Pharmaceuticals? Sonoma Pharmaceuticals has 10 investors including Ladenburg Thalmann and  Alexandria Venture Investments.When was the last funding round for Sonoma Pharmaceuticals? Sonoma Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Sonoma Pharmaceuticals's competitors? Alternatives and possible competitors to Sonoma Pharmaceuticals may include Healogics, LAVIOR, and  Sanara MedTech.How much funding has Sonoma Pharmaceuticals raised to date? Sonoma Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|